Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 415 of the 415 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. PARTICIPANTS: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and a medical writer, all appointed by The Endocrine Society. EVIDENCE: The Task Force developed this evidenced-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews of published data and considered several other existing meta-analyses and trials. CONSENSUS PROCESS: Multiple e-mail communications, conference calls, and one face-to-face meeting determined consensus. Committees of The Endocrine Society, representatives from endorsing societies, and members of The Endocrine Society reviewed and commented on the drafts of the guidelines. The Australasian Menopause Society, the British Menopause Society, European Menopause and Andropause Society, the European Society of Endocrinology, and the International Menopause Society (co-sponsors of the guideline) reviewed and commented on the draft. CONCLUSIONS: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the climacteric. Benefits may exceed risks for the majority of symptomatic postmenopausal women who are under age 60 or under 10 years since the onset of menopause. Health care professionals should individualize therapy based on clinical factors and patient preference. They should screen women before initiating MHT for cardiovascular and breast cancer risk and recommend the most appropriate therapy depending on risk/benefit considerations. Current evidence does not justify the use of MHT to prevent coronary heart disease, breast cancer, or dementia. Other options are available for those with vasomotor symptoms who prefer not to use MHT or who have contraindications because these patients should not use MHT. Low-dose vaginal estrogen and ospemifene provide effective therapy for the genitourinary syndrome of menopause, and vaginal moisturizers and lubricants are available for those not choosing hormonal therapy. All postmenopausal women should embrace appropriate lifestyle measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have not associated HRT in women 40-49 years with increased risk of breast cancer (161), and there is no evidence that estrogen replacement in women with premature ovarian failure relates to a higher risk of breast cancer ( 162).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [162]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 3×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
Background2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development and implementation of evidence-based guidelines (1).”
Method2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534 · cited 2×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
BackgroundClinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 2×
“Recent guidelines address bonespecific therapies (43).”
BackgroundWriting Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Cited by
Items 501–600 of 883
Climacteric Symptoms: Importance and Management
Birkhaeuser, M. H. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_4 · Cited by 5
The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview
Phua, C., & Baber, R. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0574-y · Cited by 4
CHEN(陈超), C., Ai, Y., Liu, B., & He, L. (2021) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2021.08.008 · Cited by 3
Valera, M., Fontaine, C., Noirrit‐Esclassan, E., Boudou, F., Buscato, M., Adlanmérini, M., Trémollières, F., Gourdy, P., Lenfant, F., & Arnal, J. (2018) · médecine/sciences · doi:10.1051/medsci/2018297 · Cited by 5
A Survey of Menopause Care Among US Women
Truong, S. R. (2019) · Journal of Gynecology and Obstetrics · doi:10.11648/j.jgo.20190702.11 · Cited by 3
“[13, 16] It remains to be seen how this will impact MHT use.”
BackgroundJurgens, T. M., Chan, B., Caron, C., & Whelan, A. M. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102285 · Cited by 3
The Handbook of Wellness Medicine
Snellings, J. E. (2021) · Family Medicine · doi:10.22454/fammed.2021.204951 · Cited by 3
Depression--what should the doctor ask?
Wilhelm, K. A., Brownhill, S., Harris, J., & Harris, P. (2006) · PubMed · Cited by 3
Martins, M. V. F., Rosa, G. A., Negreiros, A. F., & Soares, G. C. (2021) · Brazilian Journal of Development · doi:10.34117/bjdv7n6-690 · Cited by 3
Chionna, R., Salvatore, S., & Longhi, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-31307-3_14 · Cited by 3
Menopoz Semptomlarına Özgü Güncel Kanıt Temelli Uygulamalar
Fırat, B. Ö., & Aslan, E. (2022) · Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi · doi:10.37989/gumussagbil.943087 · Cited by 4
Hosio, M., Urpilainen, E., Hautakoski, A., Arffman, M., Sund, R., Ahtikoski, A. M., Puistola, U., Jukkola‐Vuorinen, A., Läärä, E., & Karihtala, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-65916-2 · Cited by 3
Considerations in Premature Menopause: A Review
Dave, A., Patel, D. J., Shrivastava, D., Chaudhari, K., & Manchanda, R. (2024) · Cureus · doi:10.7759/cureus.69744 · Cited by 14
Kuo, Y.-W., Kuo, C., Le, P., Chang, M., Lin, C.-Y., Hsu, C., Lin, W.-P., Chen, C.-W. D., Lin, W.-R., Ho, Y., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030638 · Cited by 3
“In females, hypogonadism can be identified by symptoms such as amenorrhea, menopause, or medical history, such as ovarian surgery [21].”
Evolving the Health Care Service Model for Menopause With Digital Health
Guille, C., Jahnke, H. R., Shah, N. T., & Henrich, N. J. (2025) · Women s Health Issues · doi:10.1016/j.whi.2025.03.005 · Cited by 4
Understanding and Prescribing Menopausal Hormone Therapy for Vasomotor Symptoms
Quaile, H., Hart-Kress, C., & Piasta, J. (2025) · Clinical Journal for Nurse Practitioners in Women s Health · doi:10.1891/cjnpwh-2510 · Cited by 2
Kaorop, W., Maneechote, C., Pratchayasakul, W., Kumfu, S., Arunsak, B., Kongkaew, A., Chattipakorn, S. C., & Chattipakorn, N. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117399 · Cited by 2
Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause
Wynchank, D., & Kooij, J. J. S. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01291-z · Cited by 2
Eriksson, R. G., Söderquist, F., Bai, G., Wikman, P., Giunta, D. H., Poromaa, I. S., Elenis, E., Hirschberg, A. L., Skalkidou, A., & Iliadis, S. I. (2026) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70225 · Cited by 3
“31 Despite evidence that trans-dermal estrogen does not increase the risk of venous thromboembolism (VTE) 32,33 and is recommended over oral formulations, 34,35 the dispensing of transdermal estrogen remained low.”
Enfrentamiento de la osteoporosis post menopáusica en la consulta ginecológica
Francisco Fuentes, Q., Cristóbal, C. O., & Adriana, D. V. (2017) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262017000600639 · Cited by 8
Relationship Between Physical Changes and Anxiety Premenopause Women in Kalasey 1 Village
Lolowang, R. M. (2022) · Interdisciplinary Social Studies · doi:10.55324/iss.v1i10.266 · Cited by 2
“During this period, there is a decrease in the levels of the hormones estrogen and progesterone, causing various changes in premenopausal women such as menstrual cycle irregularities, and hot flushes from the chest upwards which are often accompanied by profuse sweating and lasts for a few seconds to 5 minutes, feelin…”
BackgroundOkumura, A., Kondo, E., Kubo-Kaneda, M., Yoshida, K., & Ikeda, T. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2130202 · Cited by 2
“Therefore, HT is contraindicated in breast cancer and thrombosis and should be administered with caution in patients with a history of uterine or ovarian cancer (Stuenkel et al. 2015).”
BackgroundManagement of menopause: a survey of physicians from the Middle East and Africa
Beshyah, S., Alwatban, L., Ekhzaimy, A. A., Mustafa, H., Abdelmannan, D. K., Merheb, M., & Bashir, M. (2023) · Climacteric · doi:10.1080/13697137.2023.2190509 · Cited by 4
Emergency Gynecologic Considerations in the Older Woman
Cimino-Fiallos, N., & Dyne, P. L. (2023) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2023.01.004 · Cited by 2
Possibilities of reproductive function realization in patients with premature ovarian insufficiency
Abdulaeva, A. S., Игоревна, К. П., & Bakhtiyarov, K. R. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-126 · Cited by 2
Hoz, F. J. E. D. L. (2024) · Gaceta Médica Boliviana · doi:10.47993/gmb.v47i1.606 · Cited by 4
Zaidan, A. I., Nizam, A., Rob, S. A., Ashraf, N., Alshujairi, S. H., Qurban, K., Afroze, T., Khalifa, J., & Alhubaishi, L. Y. A. (2024) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_20_24 · Cited by 2
Knowledge and Awareness Toward Menopausal Hormone Therapy in a Fourth-Tier City of China
Li, R., Zhang, H., Feng, Y., Wang, Y., Wang, X., Gao, S., Dong, L., Zhao, X., Li, H., Li, L., et al. (2024) · Medical Science Monitor · doi:10.12659/msm.942577 · Cited by 2
“Menopausal hormone therapy (MHT) is the most effective treatment for managing vaso-motor and genitourinary symptoms [3,4].”
BackgroundPrescribing Menopausal Hormone Therapy
Ashraf, A. (2024) · Springer eBooks · doi:10.1007/978-981-96-0239-1_26 · Cited by 2
Marla Shapiro, C. M., Schaudig, K. T., Hirschberg, A. L., Blogg, M., Morga, A., Martins, K., & Bouchard, C. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002532 · Cited by 2
“14 Speci fi c caution is also advised in cases of cardiovascular disease, diabetes, or elevated triglyceride levels.”
Belešová, R., & Tóthová, V. (2019) · Central European Journal of Nursing and Midwifery · doi:10.15452/cejnm.2019.10.0026 · Cited by 2
“During the menopause, when women stop menstruating, they undergo the transition from the reproductive phase to the phase of reproductive rest (Stuenkel et al., 2015).”
BackgroundSiyam, T., Shivji, A., Ross, S., Eurich, D. T., Lavasanifar, A., & Yuksel, N. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001685 · Cited by 2
“Information on surgical menopause and HT were mainly gathered from current and relevant guidelines from various professional organization.(9,41,42,49,50) Since guidelines in the”
MethodKnowledge gaps and challenges in care for menopausal women
Pinkerton, J. V. (2022) · OBG Management · doi:10.12788/obgm.0203 · Cited by 2
Self-citationHormone Therapy for Menopausal Women in the Primary Care Setting
Swords, K. E. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2017.07.013 · Cited by 2
Pharmacotherapy in overactive bladder
Hopkinson, V., & Pearce, I. (2017) · Journal of Clinical Urology · doi:10.1177/2051415817738471 · Cited by 2
TESTOSTERONE REPLACEMENT THERAPY AND CARDIOVASCULAR RISK
Berdnikov, S. V., & Бердникова, О. А. (2017) · Siberian medical review · doi:10.20333/2500136-2017-2-14-21 · Cited by 2
“Дефицит половых гормонов в менопаузе у женщин и дефицит тестостерона у мужчин вызывают схожие состояния: сексуальную дисфункцию, снижение полового влечения, остеопороз, увеличение массы жировой ткани, депрессию [40].”
Perera, D. M., & Moe, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.005 · Cited by 2
Wellness Interventions in the Workplace
Chernoff, R. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.020 · Cited by 3
Sharma‐Brymer, V., Dashper, K. L., & Brymer, E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.034 · Cited by 3
Timing and type of menopause and risk of cardiovascular disease
Hickey, M., & Mishra, G. D. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001747 · Cited by 5
Influencia de la tibolona en la función sexual y seguridad cardiovascular en la mujer posmenopáusica
Hoz, F. J. E. D. L. (2022) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2022-3223 · Cited by 2
Draz, A., Jaffar, H. M., Rizwan, B., Sukhera, S., Batool, S. A., Noreen, S., Koser, N., & Islam, Z. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2228074 · Cited by 4
“The acidity of yogurt was analyzed by direct titration [17] of a 9-gram sample of yogurt with 0.1 N sodium hydro-oxides (NaOH).”
MethodInfluentialAdd-Back and Combined Regulation in GnRH-a Treatment of Endometriosis
Tang, H., Jia, Q., Dong, Z., Chen, Y., Shan, W., Wu, Y., Miao, M., Xing, T., Wei, W., Tang, B. H., et al. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5010224 · Cited by 2
“Studies have confirmed [29,30] that postoperative use of GnRH-a in EMS patients leads to peri-menopausal symptoms, seriously affecting the quality of life of patients and compliance to continue treatment.”
BackgroundKaysin, A., & Gourlay, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-71812-5_13 · Cited by 2
Hormone Therapy for Preventing Heart Failure in Postmenopausal Women
Appiah, D., & Winters, S. J. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.10.008 · Cited by 2
Gasparyan, S. A., Drosova, L. D., & Александровна, Х. А. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-2-82-86 · Cited by 2
HRT in women with cardiovascular disease: Can we start, should we stop?
Porter, A. (2017) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117696385 · Cited by 2
Mechanisms of Osteoprotective Actions of Estrogens
Kato, S., Sawatsubashi, S., Yokoyama, A., Nakamura, T., & Kouzmenko, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11273-5 · Cited by 3
Genitourinary Syndrome of Menopause
Rubin, R. S., & Simon, J. A. (2020) · Wiley eBooks · doi:10.1002/9781119482598.ch30 · Cited by 2
Long, B. J., & Bojko, A. (2020) · doi:10.1002/9781119482598.ch38 · Cited by 2
Can menopausal hormone therapy be considered in postmenopausal women who are older than 60 years?
Anagnostis, P. G., Bosdou, J. Κ., Georgiou, T., & Goulis, D. G. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2468957 · Cited by 2
“On the other hand, the Endocrine Society advises against MHT use in women >60 years of age or >10 years since FMP [8].”
Sediri, S., Madika, A., Baguet, J.-P., Mallart, A., Charley-Monaca, C., & Mounier‐Véhier, C. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.03.018 · Cited by 1
Medvedeva, I. N., & Сергеевна, С. К. (2020) · Journal of obstetrics and women s diseases · doi:10.17816/jowd69137-44 · Cited by 1
“Эксперты Эндокринологического общества по менопаузальным расстройствам считают, что лнг-вМс является эффективным средством для профилактики гиперплазии и рака эндометрия, особенно у женщин с ожирением [10].”
Menopausal hormone therapy: oncological risks
Валентиновна, М. Е., & Kogan, I. Y. (2020) · GYNECOLOGY · doi:10.26442/20795696.2020.3.200154 · Cited by 2
Well-Being and Work–Life Balance: Cultural, Positive Psychology, and Practical Perspectives
Bolton, M. A., Lobben, I., Pruzinsky, T., & Stern, T. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.046 · Cited by 3
Forgiveness, Gratitude, and Spirituality
Idicula, S. A., Thrower, N., & Lomax, J. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.029 · Cited by 1
Engaging the Five Senses: Taste, Smell, See, Listen, and Touch
Bokarius, V., & Bokarius, A. V. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.037 · Cited by 2
Wellness Interventions in Patients Living with Chronic Medical Conditions
Steiner, A. J., Aguilar-Hernandez, L., Pizano, D. R., Dascal, J., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.014 · Cited by 2
Aging Beautifully with Healthy Sexual Life
Rusda, M. (2023) · Advances in health sciences research/Advances in Health Sciences Research · doi:10.2991/978-94-6463-310-8_19 · Cited by 1
Mental Health Issues in Menopause
Kumar, V., Kumar, A., & Singh, V. (2023) · Indian Journal of Clinical Psychiatry. · doi:10.54169/ijocp.v3i01.64 · Cited by 3
Qin, L.-Q., Zhang, Z., Zhang, C., & Zhou, H. C. (2024) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2024.102404 · Cited by 1
Emerging Trends in Treatment of Hot Flashes at Menopause: A Review
Garg, R., & Balakrishnan, D. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2501 · Cited by 1
Shakoor, E., Qassemian, A., Shams, S., & Amani-Shalamzari, S. (2024) · Comparative Exercise Physiology · doi:10.1163/17552559-00001065 · Cited by 1
Chapter 1. The Reproductive Life Cycle
Lighten, A., Zein, M., Olgun, M., & Catapano, L. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg01 · Cited by 1
Improvement of menopausal symptoms by oat hull extracts in ovariectomized animal model
Lee, M., Lee, Y., Lee, H. G., Jin, H., Shin, Y., Song, S. Y., Seo, W. D., & Son, Y. (2025) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-025-00189-8 · Cited by 1
Heart matters: the unique landscape of cardiovascular health in women
Figtree, G. A., & Gray, M. P. (2025) · Climacteric · doi:10.1080/13697137.2025.2497419 · Cited by 1
Avoiding touching until 60 min—contamination of transdermal estradiol gel after physical contact
Cao, Y., Zhang, L., Wei, J., & Liao, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1524870 · Cited by 1
Saadedine, M., Banks, V., Dinkel-Keuthage, C., Janssenswillen, C., Lavallee, M., Möeller, C., Schoof, N., Vizcaya, D., Francuski, M., Golozar, A., et al. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002611 · Cited by 1
“Investigating the characteristics and preferences of breast cancer survivors receiving HT for menopausal symptoms would be a bene fi cial line of future research.”
Ramadan, S., Okda, M., Kansal, D., & Thompson, B. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.09.009 · Cited by 1
“10 These fi ndings have been in fl uential in endocrinology: guidelines now emphasize selecting transdermal routes for estrogen therapy in women at elevated baseline risk of thrombosis, such as those with prior VTE or genetic predispositions.”
Menopause and Vasomotor Symptoms: Narrative Review of Evidence and Therapeutic Perspectives
Zaiats, P. A. J. (2025) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2025.1510141 · Cited by 1
The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care
Mazza, A. D. (2025) · Cureus · doi:10.7759/cureus.98153 · Cited by 4
“…are mediated by TSHR/IGF-1R-expressing fibroblasts, studies could test GLP-1RAs as adjuncts to antithyroid drugs or biologics (for example, alongside IGF-1R blockade for orbitopathy) to reduce systemic inflammation and metabolic drivers without compromising disease control [19,25,67].”
Matters of the Heart: Menopause, Hormones, and Cardiovascular Disease
Guo, R., & Lau, E. S. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01131-0 · Cited by 2
What Causes Depression during Menopause: A Contemporary Review
Goel, M., & Shea, A. K. (2025) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-025-00453-x · Cited by 1
“HT remains the most effective treatment for VMS and vulvovaginal atrophy [69].”
Royal jelly for management of postmenopausal symptoms: a systematic review and meta-analysis
Ferraz, S. D., Stangherlin, L., Colonetti, T., Uggioni, M. L. R., Taschetto, I. S., Ceretta, L. B., Grande, A. J., & da Rosa, M. I. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002688 · Cited by 1
Cardiovascular risk in hormone replacement therapy
Barcellona, D. (2026) · Bleeding Thrombosis and Vascular Biology · doi:10.4081/btvb.2026.411 · Cited by 1
“20 The Framingham Cardiovascular Disease (CVD) Risk Score is sex-specific, validated, and estimates the 10-year risk of cardiovascular events by including variables such as age, systolic blood pressure, use of antihypertensive medications, cigarette smoking, diabetes, and HDL cholesterol…”
Age and diagnostic assessment of natural menopause in low-weight women
Stockman, S. L., Ayinon, C., Nawash, B., Desai, N., Siegel, L. B., Eljamri, S., & Fazeli, P. K. (2026) · Climacteric · doi:10.1080/13697137.2026.2631509 · Cited by 1
“Current guidelines discourage the routine use of FSH testing to diagnose menopause in women aged 45 years and older, recommending its use only when the diagnosis is uncertain or atypical features are present [1–3].”
InfluentialHe, Z., Wang, Y., Wei, T., & Li, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106684 · Cited by 2
Sylvestre, N., & Kim, C. (2017) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-017-0527-8 · Cited by 2
Stuenkel, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_15 · Cited by 1
Self-citationHormontherapie in der Peri- und Postmenopause
Meyer, S., & Seifert‐Klauss, V. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0441-4540 · Cited by 1
“Bei Einsatz einer HT wegen Arthralgien wurden Gelenksteifigkeit und -schmerzen signifikant verbessert [4, 5].”
BackgroundInfluentialAuf gutem Weg durch die Wechseljahre
Mann, C., Mahner, S., & Thaler, C. (2019) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-019-0004-z · Cited by 1
Ooi, S. L., & Pak, S. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.033 · Cited by 1
Dieppe, P. A., Goldingay, S., & Warber, S. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.042 · Cited by 3
Emotional Intelligence and Its Role in Sustaining Fulfillment in Life
Sax, H. C., & Gewertz, B. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.038 · Cited by 1
Family Relations, Friendships, and Love
Alsup, S., Weisbaum, E., Vogel, T., & Siegel, D. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.047 · Cited by 2
Genetic Disorders of Lipoprotein Metabolism
Brown, A. S., Dababneh, E. G., Chaus, A. M., Chyzhyk, V., Marinescu, V., & Pyslar, N. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_3 · Cited by 2
Die menopausale Hormontherapie aus internistisch endokrinologischer Sicht
Gärtner, R., & Albrich, W. C. (2021) · Diabetes aktuell · doi:10.1055/a-1180-3127 · Cited by 1
“Die Endocrine Society [7], die International Menopause Society [8] und zuletzt die North American Menopause Society [9], der sich viele andere wissenschaftliche Gesellschaften angeschlossen haben, betonen deren unübertroffene Wirksamkeit bei vasomotorischen Beschwerden und bestätigen die langfristigen, günstigen Effek…”
InfluentialReznichenko, G. I., & Reznichenko, N. Y. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.58.73-78 · Cited by 1
Approach to Evaluation and Comprehensive Care for Primary Ovarian Insufficiency
Weyman, E. A., McDonald, I. R., Blocker, E. S., Welt, C. K., & Dwyer, A. A. (2022) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.09.023 · Cited by 2
Role of yoga in improving pulmonary efficiency in post-menopausal women
Bhaskar, A., Kumar, B., Bhat, R. M., & Kabir, A. (2023) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20230574 · Cited by 1
Rodríguez‐Rodríguez, I., Rodríguez, J., & Campo-Valera, M. (2023) · UMA Editorial eBooks · doi:10.24310/mumaedmumaed.5 · Cited by 2
Ma, J., Chen, Y., Chiang, C., Wang, W., Chung, C., Tsao, C., Weng, Z., Hung, C., & Chien, W. (2023) · The Journal of Dermatology · doi:10.1111/1346-8138.16859 · Cited by 2
STOBBE, P. R., Tatit, U. L., Guedes, M. H., Baena, C. P., & Rech, C. M. Z. (2024) · Revista Caribeña de Ciencias Sociales · doi:10.55905/rcssv13n4-013 · Cited by 2
Menopause and HRT (use and concerns) among Jordanian women: a cross-sectional study
Albeitawi, S., Bereshy, R., Zyout, R. A., & Wasfi, G. (2024) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2024.168 · Cited by 1
Pavicic, E., Rüst, K., Ehrentraut, S., von Wolff, M., & Stute, P. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07632-w · Cited by 1
Review of Guidelines on Clonidine for Various Indications
CADTH (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.955 · Cited by 1
Cooling the flames: Navigating menopausal vasomotor symptoms with nonhormone medications
Carson, E., Vernon, V. P., Cunningham, L., & Mathew, S. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae254 · Cited by 1
Chapter 18. Trauma and Reproductive Health
Gopalan, P. R., Albertini, E., Amin, P., Curley, M., Glance, J. B., Kalia, S., & Shenai, N. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg18 · Cited by 3
Effect of Low-Dose Hormone Therapy on Metabolic Parameters and Bone Mineral Density
Atlıhan, U., Yavuz, O., Avşar, H. A., Ata, C., Bıldacı, T. B., & Erkılınç, S. (2024) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2023.1520 · Cited by 1
Basheer, S., & Singh, S. G. (2025) · Journal of the Epidemiology Foundation of India · doi:10.56450/jefi.2025.v3i01.005 · Cited by 2
Metadata
- Authors
- Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-11
- Volume
- 100
- Issue
- 11
- Pages
- 3975-4011
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2162957019
- Cited by
- 884
- References
- 414
- Citations by year
- 2026: 79 · 2025: 96 · 2024: 66 · 2023: 69 · 2022: 82 · 2021: 96 · 2020: 121 · 2019: 89 · 2018: 75 · 2017: 57 · 2016: 47 · 2015: 4
- FWCI
- 52.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- menopause, hormone replacement therapy, vasomotor symptoms, climacteric, postmenopausal women, cardiovascular risk screening, breast cancer risk, ospemifene, vaginal estrogen, genitourinary syndrome of menopause, vaginal moisturizers, lifestyle intervention, personalized treatment
- MeSH terms
- Contraindications, Age Factors, Breast Neoplasms, Cardiovascular Diseases, Female, Humans, Menopause, Terminology as Topic, Risk Factors, Severity of Illness Index, Estrogen Replacement Therapy, Evidence-Based Medicine, Hot Flashes, Female Urogenital Diseases, Venous Thromboembolism, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.